Mechanism of action of topoisomerase II-targeted antineoplastic drugs

Adv Pharmacol. 1994:29B:105-26. doi: 10.1016/s1054-3589(08)61134-5.
No abstract available

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Amsacrine / pharmacology
  • Animals
  • Anti-Infective Agents / pharmacology*
  • Antineoplastic Agents / pharmacology*
  • DNA Damage*
  • DNA Topoisomerases, Type II / physiology
  • DNA, Neoplasm / drug effects*
  • Doxorubicin / pharmacology
  • Fluoroquinolones
  • Humans
  • Mitoxantrone / pharmacology
  • Topoisomerase II Inhibitors*

Substances

  • Anti-Infective Agents
  • Antineoplastic Agents
  • DNA, Neoplasm
  • Fluoroquinolones
  • Topoisomerase II Inhibitors
  • Amsacrine
  • Doxorubicin
  • Mitoxantrone
  • DNA Topoisomerases, Type II